Richard Purcell posted this on LinkedIn: “The
Post# of 36537
“The research reported here highlights the dangers of a non-specific immune reaction gone wild in COVID-19 patients. The T Helper Cell response that triggers the B Cell antibody response is impaired. This is why Generex’ Ii-Key-SARS-CoV-2 vaccine holds so much promise. The Ii-Key technology activates the T Helper Cell response to modulate the communication with B Cells that make neutralizing antibodies and provide immunologic memory.”
https://www-nytimes-com.cdn.ampproject.org/c/...m.amp.html